中国循环杂志2024,Vol.39Issue(8) :781-784.DOI:10.3969/j.issn.1000-3614.2024.08.007

经静脉导线拔除后植入全皮下埋藏式心脏复律除颤器的临床结果

Clinical Results of Implantation of Subcutaneous Implantable Cardioverter Defibrillator After Transvenous Lead Extraction

苑翠珍 昃峰 李鼎 段江波 吴寸草 何金山 周旭 王龙 李学斌
中国循环杂志2024,Vol.39Issue(8) :781-784.DOI:10.3969/j.issn.1000-3614.2024.08.007

经静脉导线拔除后植入全皮下埋藏式心脏复律除颤器的临床结果

Clinical Results of Implantation of Subcutaneous Implantable Cardioverter Defibrillator After Transvenous Lead Extraction

苑翠珍 1昃峰 1李鼎 1段江波 1吴寸草 1何金山 1周旭 1王龙 1李学斌1
扫码查看

作者信息

  • 1. 北京大学人民医院 心内科,北京 100044
  • 折叠

摘要

目的:评估没有起搏指征的静脉埋藏式心脏复律除颤器(TV-ICD)患者经静脉导线拔除(TLE)后植入全皮下埋藏式心脏复律除颤器(S-ICD)的安全性和有效性.方法:连续纳入 2018 年 6 月至 2023 年 10 月于北京大学人民医院行TLE后再植入S-ICD的所有患者.统计并分析TLE指征、S-ICD植入适应证、除颤阈值(DFT)测试、并发症及术后随访情况.结果:共有 11 例TV-ICD患者在TLE后接受了S-ICD植入,男性 8 例,中位年龄 56(44,65)岁.TLE的指征为感染和导线功能障碍.ICD二级预防的有 9 例患者,最常见的植入原因是离子通道疾病(5 例).S-ICD的手术时间为 51(48,58)min,未发现围术期并发症.8 例患者进行了DFT测试,全部成功.在中位 30(9,39)个月的随访中,2 例患者共发生 6 次适当的治疗,无并发症发生,包括不适当的治疗、无效治疗、感染、导线故障和死亡.结论:本研究为S-ICD作为TV-ICD移除后的替代提供了依据.TLE后植入S-ICD是安全有效的.

Abstract

Objectives:To evaluate the safety and efficacy of implantation of subcutaneous implantable cardioverter defibrillator(S-ICD)after transvenous lead extraction(TLE)in ICD patients without pacing indications.Methods:All patients who underwent TLE at Peking University People's Hospital from June 2018 to October 2023 were consecutively included.TLE indication,S-ICD implantation indication,defibrillation threshold(DFT)test,complications and postoperative follow-up were collected and analyzed.Results:A total of 11 patients with TV-ICD underwent S-ICD implantation after TLE,eight patients were males and median age were 56(44,65)years.The indications for TLE were infection and lead dysfunction.Nine patients were implanted with S-ICD for secondary prevention,and the most common cause of implantation was ion channelopathies(5 cases).The operative time for S-ICD was 51(48,58)minutes and no perioperative complications were noted.Eight patients underwent DFT testing,and 100%were successful.During a median follow up of 30(9,39)months,a total of six appropriate treatments occurred in two patients,and no complications occurred,including inappropriate treatment,ineffective treatment,infection,lead malfunction and death.Conclusions:Our study provides evidence for S-ICD implantation as a replacement after TV-ICD removal.The S-ICD implantation after TLE is safe and effective.

关键词

埋藏式心脏复律除颤器/全皮下埋藏式心脏复律除颤器/经静脉导线拔除

Key words

implantable cardioverter defibrillator/subcutaneous implantable cardioverter defibrillator/transvenous lead extraction

引用本文复制引用

出版年

2024
中国循环杂志
中国医学科学院

中国循环杂志

CSTPCDCSCD北大核心
影响因子:2.803
ISSN:1000-3614
参考文献量5
段落导航相关论文